Collaboration will create selective, ready-to-use HPLC columns to support process analytical technology.

BAC will bring its CaptureSelect® ligands for affinity purification of antibodies to Life Technologies’ Poros® chromatography media and prepacked HPLC columns under a strategic collaboration. The suite of products is intended to provide a broad range of specificities and column formats for applications from discovery through to process monitoring.

The collaboration will result in a variety of ready-to-use HPLC columns prepacked with CaptureSelect affinity ligands immobilized on Poros chromatography media. The selectivity of the columns is designed to support Process Analytical Technology for virtually any biopharmaceutical manufacturing process.

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments. CaptureSelect’s affinity purification and separation products are provided for the discovery, preclinical, and clinical manufacturing of therapeutic proteins including antibodies and antibody fragments.

Previous articleAbbott Pays Biotest $85M Up Front in Deal for Phase II mAb Against RA and Psoriasis
Next articleWhat Does It Take to Swing the IPO Window Open for Biotechs?